lactobacillus farciminis
Cell therapyexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2007 (NCT00561535)
Timeline
Indications
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- lactobacillus farciminis
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00852865 | Phase 1 | Feb 1, 2009 | Lallemand SAS, University Clermont Auvergne |
| NCT00561535 | Phase 2 | Oct 1, 2007 | Association pour l'Etude des Fonctions Digestives, University of Paris |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Association pour l'Etude des Fonctions Digestives | Academic/Hospital | 1 | 0 | 1 | 2007 |
| Lallemand SAS | For profit | 1 | 1 | 1 | 2009 |
| University Clermont Auvergne | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Paris | Academic/Hospital | 1 | 1 | 1 | 2007 |
4 organizations
Page 1 / 1